Co-occurrence of BCR-ABL1 rearrangement and CALR mutation in a single leukemic stem cell: evidence that BCR-ABL1 oncogenic addiction prevails over CALR signaling

被引：4

作者：

Balducci, Estelle ^{[1
,2
]}

Sanekli, Safa ^{[1
,3
]}

Hugues, Patricia ^{[1
]}

Soubeyrand, Mathis ^{[1
]}

Borie, Claire ^{[2
]}

Fund, Xavier ^{[2
]}

Desterke, Christophe ^{[1
,2
]}

Aumont, Cedric ^{[3
]}

Faivre, Jamila ^{[2
,4
]}

Bennaceur-Griscelli, Annelise ^{[1
,2
,3
,5
]}

Turhan, Ali G. ^{[1
,2
,3
,5
]}

机构：

[1] INSERM, UMR 935, Villejuif, France

[2] Hop Paul Brousse, Assistance Publ Hop Paris, Serv Hematol, Villejuif, France

[3] Hop Bicetre, Assistance Publ Hop Paris, Serv Hematol, Le Kremlin Bicetre, France

[4] INSERM, Ctr Hepatobiliaire, UMR 785, Villejuif, France

[5] INGESTEM ESteam Pluripotent Stem Cell Infrastruct, Villejuif, France

来源：

LEUKEMIA & LYMPHOMA | 2020年 / 61卷 / 01期

关键词：

CHRONIC MYELOID-LEUKEMIA;

D O I：

10.1080/10428194.2019.1658101

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：209 / 212

页数：4

共 12 条

[1] The co-occurrence of driver mutations in chronic myeloproliferative neoplasms [J].

Boddu, Prajwal ;

Chihara, Dai ;

Masarova, Lucia ;

Pemmaraju, Naveen ;

Patel, Keyur P. ;

Verstovsek, Srdan .

ANNALS OF HEMATOLOGY, 2018, 97 (11) :2071-2080

[2] CALR-mutated essential thrombocythemia evolving to chronic myeloid leukemia with coexistent CALR mutation and BCR-ABL translocation [J].

Bonzheim, Irina ;

Mankel, Barbara ;

Klapthor, Peter ;

Schmidt, Janine ;

Hinrichsen, Tanja ;

Wachter, Oliver ;

Fend, Falko ;

Quintanilla-Martinez, Leticia .

BLOOD, 2015, 125 (14) :2309-2311

[3] A CALR Mutation Preceding BCR-ABL1 in an Atypical Myeloproliferative Neoplasm [J].

Cabagnols, Xenia ;

Cayuela, Jean-Michel ;

Vainchenker, William .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (07) :688-690

[4]

Choi Sarah M, 2017, Leuk Res Rep, V8, P11, DOI 10.1016/j.lrr.2017.09.001

[5]

Dogliotti Irene, 2017, Stem Cell Investig, V4, P57, DOI 10.21037/sci.2017.06.02

[6] Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines [J].

Feraud, Olivier ;

Valogne, Yannick ;

Melkus, Michael W. ;

Zhang, Yanyan ;

Oudrhiri, Noufissa ;

Haddad, Rima ;

Daury, Aurelie ;

Rocher, Corinne ;

Larbi, Aniya ;

Duquesnoy, Philippe ;

Divers, Dominique ;

Gobbo, Emilie ;

de la Grange, Philippe Brunet ;

Louache, Fawzia ;

Bennaceur-Griscelli, Annelise ;

Mitjavila-Garcia, Maria Teresa .

PLOS ONE, 2016, 11 (03)

[7] Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors [J].

Helbig, Grzegorz .

MEDICAL ONCOLOGY, 2018, 35 (09)

[8] Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1 [J].

Loghavi, Sanam ;

Pemmaraju, Naveen ;

Kanagal-Shamanna, Rashmi ;

Mehrotra, Meenakshi ;

Medeiros, L. Jeffrey ;

Luthra, Raja ;

Lin, Pei ;

Huh, Yang ;

Kantarjian, Hagop M. ;

Cortes, Jorge E. ;

Verstovsek, Srdan ;

Patel, Keyur P. .

BLOOD, 2015, 125 (21) :3360-3363

[9] Cytogenetics of chronic myelogenous leukaemia [J].

OBrien, S ;

Thall, PF ;

Siciliano, MJ .

BAILLIERES CLINICAL HAEMATOLOGY, 1997, 10 (02) :259-276

[10] Concurrent or Sequential BCR-ABL Translocation and Calr gene or JAK2V617F Mutation [J].

Pagoni, Maria ;

Garofalaki, Maria ;

Tziotziou, Irene ;

Nikolou, Evaggelia ;

Karakatsanis, Stamatis ;

Tsonis, Ioannis ;

Zoi, Katerina ;

Baltathakis, Ioannis ;

Karakasis, Dimitrios ;

Harhalakis, Nikolaos .

BLOOD, 2014, 124 (21)

← 1 2 →